Nurexone Biologic has received a notice of allowance from the U.S. Patent and Trademark Office for a patent covering...

Immix Biopharma has secured a strategic investment from Goose Capital and Dr. Nancy T. Chang, the former Tanox CEO...

Cosmos Health’s Sky Pharm has signed a distribution agreement with Scientific Pharmacy, the retail and wholesale arm of Planet...

Cardiac Biotech Solutions has booked an initial international order for 2,500 MyCardia AT cardiac event monitoring devices from Noventis...

FOXO Technologies has signed a stock purchase agreement to acquire Vector BioSource, an information, data, and biospecimen sourcing provider...

Scancell released full-year results alongside a business update anchored by positive phase 2 melanoma data and a more straightforward...

BioVersys has entered the late-stage development of antimicrobial resistance. Following a successful end-of-Phase-2 meeting with the FDA, the company...

BioVersys reported a busy first half: a successful end-of-Phase two meeting with the FDA for BV100 in ventilator-associated bacterial...

Scancell has reported robust Phase 2 data for its next-generation DNA vaccine iSCIB1+ in advanced melanoma, confirmed plans to...

BioVersys has set a 2025 start for a global Phase 3 program of BV100 in ventilator- and hospital-acquired bacterial...